New stress testing protocol to study heart issues in women with chest pain
Official title: DEVELOPMENT OF A NOVEL STRESS TESTING PROTOCOL TO DEFINE THE RELATIONSHIP BETWEEN CORONARY MICROVASCULAR DYSFUNCTION AND DIASTOLOGY IN WOMEN WITH ANGINA BUT NO EVIDENCE OF OBSTRUCTIVE CORONARY ARTERY DISEASE
Run by Cedars-Sinai Medical Center · NCT02301663 · Data updated 2026-11-12
This study is testing a new way to understand heart problems in women with chest pain but no blocked arteries, to see how their heart functions during stress.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | Women only |
| Enrollment | 30 (estimated) |
| Sponsor | Cedars-Sinai Medical Center Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Status | Recruiting |
| Started | November 2014 |
| Main results expected | December 2030 |
| Study ends | December 2030 |
| Registry record updated | September 1, 2023 |
| Trial ID | NCT02301663 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include women over 18 years old who experience chest pain and have been diagnosed with microvascular coronary dysfunction.
✕Probably not a fit
Patients with a history of cardiovascular, pulmonary, or neurological diseases, or those with hypertension, diabetes, or contraindications to cardiac MRI will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to explore the relationship between coronary microvascular dysfunction and heart relaxation in women experiencing chest pain but without obstructive coronary artery disease. It will involve 30 participants, including healthy individuals and women diagnosed with microvascular disease, who will undergo various stress maneuvers alongside advanced cardiac magnetic resonance imaging. The goal is to better understand the pathophysiology of microvascular coronary dysfunction and its impact on heart function.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and treatment options for women suffering from microvascular coronary dysfunction.
How similar studies have gone: While this approach is novel in its specific focus on women with microvascular dysfunction, similar studies have shown promise in understanding coronary microvascular disease.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Fully understanding and willing to undergo study procedures 2. Male or Female greater than or equal to 18 years of age 3. Understanding and willing to sign consent form. Exclusion Criteria: 1. History of cardiovascular, pulmonary, or neurological disease 2. Hypertension (sitting blood pressure \>140/90 mmHg, with measurements recorded on at least 2 occasions) 3. Diabetes 4. Unable to give informed consent; 5. Contra-indication to CMRI testing, including claustrophobia and metallic implants 6. Adherence or retention issues; 7. Women who are pregnant. 8. Allergy to animal dander.
Where it's running
-
Cedars-Sinai Medical Center
Los Angeles, California, United States Recruiting
Study contacts
- Principal investigator: Michael Nelson, PhD — Cedars-Sinai Medical Center
- Study coordinator: Barbra Streisand Women's Heart Center
- Phone: 310-423-9666
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Personalized exercise and dietary program for patients with microvascular coronary dysfunction
This study is testing a personalized exercise and diet program to see if it helps people with microvascular coronary dysfunction feel better and manage their symptoms.
-
Investigating heart function and blood markers in women with coronary dysfunction
This study is testing how heart function and certain blood markers are related in women with coronary issues and men, to help understand heart failure better.
-
Fisetin for Lung Health in Older Adults
Researchers are testing whether a short course of the supplement fisetin can improve lung function and aging-related biomarkers in people 60 and older, including both smokers and never-smokers.
-
Transcatheter vs. Surgical Repair for Degenerative Mitral Valve Disease
This study compares TEER, a catheter-based repair, with traditional surgical mitral repair in people aged 60 and older with degenerative mitral valve disease to see which approach works better in the long run.
-
Combining IV immunotherapy with liver-directed procedures to downstage hepatocellular carcinoma
This tests whether giving IV immunotherapy (tremelimumab plus durvalumab) together with a liver-directed procedure (Y90, TACE, or RFA) can shrink or control hepatocellular carcinoma in adults with intermediate or advanced disease so more people may become eligible for liver transplant.
-
TAVR vs SAVR for severe bicuspid aortic valve stenosis
This trial tests whether TAVR or SAVR works better for people with severe bicuspid aortic valve stenosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.